Oncology Institute (DFPH) Current Assets (2019 - 2026)

Oncology Institute (DFPH) has reported Current Assets for 8 consecutive years, with $116.9 million the latest figure, recorded in Q1 2026.

• Current Assets for Q1 2026 came in at $116.9 million, up 9.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $116.9 million (up 9.4% YoY), and the FY2025 annual result was $112.7 million, changed 0.29% from the prior year.
• Current Assets was $116.9 million for Q1 2026 at Oncology Institute, up from $112.7 million in the prior quarter.
• Over five years, Current Assets peaked at $152.7 million in Q3 2023 and troughed at $104.1 million in Q2 2023.
• Average Current Assets over 5 years is $122.5 million, with a median of $116.4 million recorded in 2024.
• Year-over-year, Current Assets jumped 49926.47% in 2022 and declined 24.34% in 2025.
• Over 5 years, Current Assets stood at $130.4 million in 2022, then gained by 10.03% to $143.5 million in 2023, then decreased by 21.66% to $112.4 million in 2024, then advanced by 0.29% to $112.7 million in 2025, then rose by 3.65% to $116.9 million in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $116.9 million in Q1 2026, $112.7 million in Q4 2025, and $110.1 million in Q3 2025.